Stephen J Hoffman's Net Worth

$2.31 Million

Estimate Recalculated Nov 1, 2024 03:33AM EST

Who is Stephen J Hoffman?

Stephen J Hoffman has an estimated net worth of $2.31 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, Sirtris Pharmaceuticals, Inc., TETRAPHASE PHARMACEUTICALS INC, Aerpio Pharmaceuticals, Inc., Research Alliance Corp. II, GENOCEA BIOSCIENCES, INC., TALPHERA, INC., and ALLOS THERAPEUTICS INC.

SEC CIK

Stephen J Hoffman's CIK is 0001190418

Past Insider Trading and Trends

2010 was Stephen J Hoffman's most active year for acquiring shares with 7 total transactions. Stephen J Hoffman's most active month to acquire stocks was the month of May. 2010 was Stephen J Hoffman's most active year for disposing of shares, totalling 12 transactions. Stephen J Hoffman's most active month to dispose stocks was the month of December. 2017 saw Stephen J Hoffman paying a total of $3,223,066.00 for 611,012 shares, this is the most they've acquired in one year. In 2021 Stephen J Hoffman cashed out on 197,823 shares for a total of $618,005.25, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dicerna Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-16.16K
$38.25
-$618,005.25
0
Dec 28
Form 4
+12.95%
3.33K
—
—
29.07K
Jun 3
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jul 18
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Apr 16
Form 4
∞
1.73M
$15.00
—
1.73M
Feb 4
Form 3
—
0
—
—
0
No matching records found

Sirtris Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.85M
—
—
1.85M
May 29
Form 3
—
0
—
—
0
No matching records found

TETRAPHASE PHARMACEUTICALS INC No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-13.49%
-295.51K
—
—
1.89M
Mar 12
No matching records found

Aerpio Pharmaceuticals, Inc. (AADI) Snapshot price: $1.82

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 14
Form 4
—
0
—
—
0
Feb 15
Form 4
∞
31.97K
$2.01
$64,135.65
31.97K
Nov 9 - Nov 12
Form 4
—
0
—
—
0
Apr 23
Form 4
—
0
—
—
0
Dec 14
Form 3
—
0
—
—
0
No matching records found

Research Alliance Corp. II No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found